Beghini A - Search Results

1

Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified.

Iurlo A, Fracchiolla NS, Ferla V, Cassin R, Gottardi E, Beghini A, Gianelli U, Spinelli O, Cortelezzi A. Iurlo A, et al. Among authors: beghini a. J Clin Oncol. 2014 Apr 1;32(10):e37-9. doi: 10.1200/JCO.2012.48.0665. Epub 2014 Jan 21. J Clin Oncol. 2014. PMID: 24449233 No abstract available.

2

Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response.

Iurlo A, Gianelli U, Beghini A, Spinelli O, Orofino N, Lazzaroni F, Cambiaghi S, Intermesoli T, Rambaldi A, Cortelezzi A. Iurlo A, et al. Among authors: beghini a. Oncotarget. 2014 Jul 15;5(13):4665-70. doi: 10.18632/oncotarget.1941. Oncotarget. 2014. PMID: 25015329 Free PMC article.

3

Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases.

Cairoli R, Beghini A, Morello E, Grillo G, Montillo M, Larizza L, Morra E. Cairoli R, et al. Among authors: beghini a. Leuk Res. 2005 Apr;29(4):397-400. doi: 10.1016/j.leukres.2004.10.005. Epub 2005 Jan 12. Leuk Res. 2005. PMID: 15725473

4

STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade.

Beghini A, Bellini M, Magnani I, Colapietro P, Cairoli R, Morra E, Larizza L. Beghini A, et al. Exp Hematol. 2005 Jun;33(6):682-8. doi: 10.1016/j.exphem.2005.03.007. Exp Hematol. 2005. PMID: 15911092 Free article.

5

Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription.

Beghini A. Beghini A. Cancers (Basel). 2019 Dec 7;11(12):1973. doi: 10.3390/cancers11121973. Cancers (Basel). 2019. PMID: 31817911 Free PMC article. Review.

6

FZD6 triggers Wnt-signalling driven by WNT10B^IVS1 expression and highlights new targets in T-cell acute lymphoblastic leukemia.

Cassaro A, Grillo G, Notaro M, Gliozzo J, Esposito I, Reda G, Trojani A, Valentini G, Di Camillo B, Cairoli R, Beghini A. Cassaro A, et al. Among authors: beghini a. Hematol Oncol. 2021 Aug;39(3):364-379. doi: 10.1002/hon.2840. Epub 2021 Feb 16. Hematol Oncol. 2021. PMID: 33497493 Free PMC article.

7

Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence.

Volpi L, Beghini A, Rossi D, Larizza L. Volpi L, et al. Among authors: beghini a. Mamm Genome. 1996 Sep;7(9):682-5. doi: 10.1007/s003359900205. Mamm Genome. 1996. PMID: 8703122

8

c-kit activating mutations and mast cell proliferation in human leukemia.

Beghini A, Larizza L, Cairoli R, Morra E. Beghini A, et al. Blood. 1998 Jul 15;92(2):701-2. Blood. 1998. PMID: 9657776 Free article. No abstract available.

9

In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.

Beghini A, Cairoli R, Morra E, Larizza L. Beghini A, et al. Blood Cells Mol Dis. 1998 Jun;24(2):262-70. doi: 10.1006/bcmd.1998.0191. Blood Cells Mol Dis. 1998. PMID: 9714703

10

C-kit mutations in core binding factor leukemias.

Beghini A, Peterlongo P, Ripamonti CB, Larizza L, Cairoli R, Morra E, Mecucci C. Beghini A, et al. Blood. 2000 Jan 15;95(2):726-7. Blood. 2000. PMID: 10660321 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters